YU45077B - Process for obtaining a monoclonal antibody - Google Patents

Process for obtaining a monoclonal antibody

Info

Publication number
YU45077B
YU45077B YU3064/80A YU306480A YU45077B YU 45077 B YU45077 B YU 45077B YU 3064/80 A YU3064/80 A YU 3064/80A YU 306480 A YU306480 A YU 306480A YU 45077 B YU45077 B YU 45077B
Authority
YU
Yugoslavia
Prior art keywords
monoclonal antibody
obtaining
hybrid
caf
immunized
Prior art date
Application number
YU3064/80A
Other languages
English (en)
Other versions
YU306480A (en
Inventor
P C S Kung
G Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22277970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU45077(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Priority to SI8013064A priority Critical patent/SI8013064A8/sl
Publication of YU306480A publication Critical patent/YU306480A/xx
Publication of YU45077B publication Critical patent/YU45077B/xx
Priority to HR940823A priority patent/HRP940823B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2881Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hybrid Cells (AREA)
YU3064/80A 1979-12-04 1980-12-03 Process for obtaining a monoclonal antibody YU45077B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI8013064A SI8013064A8 (sl) 1979-12-04 1980-12-03 Postopek za pripravo monoklonalnega protitelesa
HR940823A HRP940823B1 (en) 1979-12-04 1994-10-26 Hybrid cell line for producing monoclonal antibody to a human early thymocite antigen, antibody and method of preparation of this antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/100,071 US4364934A (en) 1979-12-04 1979-12-04 Monoclonal antibody to a human early thymocyte antigen and methods for preparing same

Publications (2)

Publication Number Publication Date
YU306480A YU306480A (en) 1984-04-30
YU45077B true YU45077B (en) 1992-03-10

Family

ID=22277970

Family Applications (1)

Application Number Title Priority Date Filing Date
YU3064/80A YU45077B (en) 1979-12-04 1980-12-03 Process for obtaining a monoclonal antibody

Country Status (20)

Country Link
US (1) US4364934A (US06623731-20030923-C00012.png)
EP (1) EP0030814B1 (US06623731-20030923-C00012.png)
JP (2) JPS5695122A (US06623731-20030923-C00012.png)
AT (1) ATE13693T1 (US06623731-20030923-C00012.png)
AU (1) AU545181B2 (US06623731-20030923-C00012.png)
CA (1) CA1175367A (US06623731-20030923-C00012.png)
DE (2) DE3070745D1 (US06623731-20030923-C00012.png)
DK (1) DK153891C (US06623731-20030923-C00012.png)
ES (1) ES497424A0 (US06623731-20030923-C00012.png)
FI (1) FI75599C (US06623731-20030923-C00012.png)
HK (1) HK24186A (US06623731-20030923-C00012.png)
IE (1) IE50724B1 (US06623731-20030923-C00012.png)
IL (1) IL61621A (US06623731-20030923-C00012.png)
MY (1) MY8600518A (US06623731-20030923-C00012.png)
NO (1) NO159887C (US06623731-20030923-C00012.png)
NZ (1) NZ195648A (US06623731-20030923-C00012.png)
PH (1) PH17490A (US06623731-20030923-C00012.png)
PT (1) PT72145B (US06623731-20030923-C00012.png)
YU (1) YU45077B (US06623731-20030923-C00012.png)
ZA (1) ZA807562B (US06623731-20030923-C00012.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624925A (en) * 1979-12-04 1986-11-25 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods
US4691010A (en) * 1979-12-04 1987-09-01 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, and methods
US4434156A (en) 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5100777A (en) * 1987-04-27 1992-03-31 Tanox Biosystems, Inc. Antibody matrix device and method for evaluating immune status
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5252711A (en) * 1989-06-01 1993-10-12 The Gillette Company Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
SE503225C2 (sv) * 1991-10-30 1996-04-22 Leif Lindholm Konsult Ab Virus-antikroppskomplex för införing av virus i mammalieceller
TR199800233T1 (xx) 1995-08-16 1998-06-22 Zeneca Limited Kimyasal bile�ikler.
CA2310805A1 (en) 1997-11-24 1999-06-03 Johnson T. Wong Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system
PL3292149T3 (pl) 2015-05-04 2022-03-21 Cytomx Therapeutics, Inc. Aktywowalne przeciwciała anty-cd71 i sposoby ich stosowania

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
DE3070745D1 (en) 1985-07-11
JPS6363557B2 (US06623731-20030923-C00012.png) 1988-12-07
FI75599C (fi) 1988-07-11
NO159887C (no) 1989-02-15
YU306480A (en) 1984-04-30
EP0030814A3 (en) 1981-12-30
AU6496180A (en) 1981-06-11
JPS5695122A (en) 1981-08-01
DK153891C (da) 1989-02-20
PT72145B (en) 1982-07-05
PH17490A (en) 1984-09-04
ES8301636A1 (es) 1983-01-01
ZA807562B (en) 1982-07-28
JPH0159869B2 (US06623731-20030923-C00012.png) 1989-12-20
DK517280A (da) 1981-06-05
DE30814T1 (de) 1984-07-19
NZ195648A (en) 1984-07-06
EP0030814A2 (en) 1981-06-24
JPS6463376A (en) 1989-03-09
IE802510L (en) 1981-06-04
IE50724B1 (en) 1986-06-25
MY8600518A (en) 1986-12-31
ES497424A0 (es) 1983-01-01
ATE13693T1 (de) 1985-06-15
FI75599B (fi) 1988-03-31
FI803756L (fi) 1981-06-05
AU545181B2 (en) 1985-07-04
IL61621A (en) 1984-07-31
HK24186A (en) 1986-04-11
CA1175367A (en) 1984-10-02
NO803660L (no) 1981-06-05
NO159887B (no) 1988-11-07
EP0030814B1 (en) 1985-06-05
PT72145A (en) 1981-01-01
US4364934A (en) 1982-12-21
DK153891B (da) 1988-09-19

Similar Documents

Publication Publication Date Title
YU306780A (en) Process for obtaining a monoclonal antibody
YU44957B (en) Process for obtaining a monoclonal antibody
YU327580A (en) Process of obtaining a monoclonal antibody
YU306580A (en) Process for obtaining a monoclonal antibody
YU74280A (en) Process for obtaining a monoclonal antibody
YU45077B (en) Process for obtaining a monoclonal antibody
IE802508L (en) Monoclonal antibody to thymocytes